Watch CBS News

The impact of the FDA's approval of the first 'biosimilar' drug

The FDA has approved a biosimilar version of the cancer drug Neupogen, created using living cells rather than chemicals. As CBS News chief medical correspondent Dr. Jon LaPook explains, it’s the first step toward lowering the cost of highly effective yet very expensive treatments.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.